EUVIMEDEUVIMED entdecken
Crossref

Incensole enhances anti-tumor immunity and inhibits melanoma progression by modulating macrophage polarization and suppressing metastasis

Fatemeh Jamshidi-Adegani, Juhaina Al-Kindi, Saeid Vakilian, Fahad Al-Fahdi, Raziyeh Rezaei, Salim Al-Adawi, Nasar Alwahaibi, Asem Shalaby, Ahmed Al-Harrasi, Sulaiman Al-Hashmi

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-025-04727-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Fatemeh Jamshidi-Adegani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Stem Cell and Regenerative Medicine, Natural and Medical Sciences Research Center, University of Nizwa, P. O. Box: 33, 616, Nizwa, Oma…. Hauptthemen laut MEDLINE: Macrophages, Melanoma, Diterpenes, Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Ministry of Higher Education, Research and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Cutaneous melanoma, a highly aggressive skin cancer, has limited treatment options. This study explores incensole (Inc) and incensole acetate (IncA), diterpenes from Boswellia species, as immunomodulatory agents capable of reshaping the tumor microenvironment to suppress melanoma progression. METHODS: In vitro, Inc and IncA cytotoxicity was evaluated against SK-MEL-28 cells, HUVECs, and fibroblasts to assess tumor selectivity. SK-MEL-28 cell migration was measured to evaluate anti-metastatic potential. P53, P21, CDK2 expression, and IL-1β secretion were quantified by real-time PCR and ELISA to elucidate molecular effects. Macrophage polarization was analyzed for immunomodulation. In vivo, Inc and IncA efficacy on a B16F10 Red-FLuc model was monitored via bioluminescence, with VEGF, TNF-α, IL-6 levels and histopathology assessed. RESULTS AND CONCLUSION: Both compounds showed selective cytotoxicity against SK-MEL-28 cells. Inc induced p53-mediated cell cycle arrest and apoptosis by upregulating P21 and downregulating CDK2, while promoting M1 macrophage polarization. Both reduced M2 markers and IL-1β secretion, mitigating tumor-promoting inflammation. Migration was inhibited, with Inc outperforming IncA. In vivo, Inc significantly lowered tumor burden, metastasis, VEGF, NO, and IL-6 levels, while increasing TNF-α, immune infiltration, and apoptosis. IncA reduced IL-6 and TNF-α but had milder effects on tumor burden. Histopathology confirmed Inc's superior immune activation and tumor suppression. Inc and IncA exhibit potent anti-melanoma effects through distinct immunomodulatory and tumor-suppressive mechanisms. Inc's greater efficacy positions it as a lead candidate, while IncA's subtler effects suggest potential as an adjunct therapy. These findings warrant further investigation into their combined therapeutic potential for melanoma management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesMelanomaDiterpenesSkin NeoplasmsMelanoma, ExperimentalAntineoplastic AgentsAnimalsHumansCell Line, TumorMiceMice, Inbred C57BLCell MovementDisease ProgressionApoptosisTumor MicroenvironmentNeoplasm Metastasis

Stichwörter der Autor:innen

AngiogenesisCutaneous melanomaImmunomodulationIncensoleIncensole acetatePolarization

Substanzen

DiterpenesAntineoplastic Agents

Autor:innen und Institutionen

  • Laboratory for Stem Cell and Regenerative Medicine, Natural and Medical Sciences Research Center, University of Nizwa, P. O. Box: 33, 616, Nizwa, Oman.
  • Doctoral Programme in Biomedicine, Faculty of Medicine, University of Helsinki, 00014, Helsinki, Finland.
  • Department of Biomedical Science, College of Medicine & Health Sciences, Sultan Qaboos University, Alkoudh.123, P. O. Box: 35, Muscat, Oman.
  • Department of Pathology, College of Medicine & Health Sciences, Sultan Qaboos University, Alkoudh.123, P. O. Box: 35, Muscat, Oman.
  • College of Medicine, Mansoura University, Mansoura, 35516, Egypt.
  • Laboratory for Stem Cell and Regenerative Medicine, Natural and Medical Sciences Research Center, University of Nizwa, P. O. Box: 33, 616, Nizwa, Oman. sahashmi@unizwa.edu.om.

Förderung

  • Ministry of Higher Education, Research and Innovation

Zitieren

APA

Jamshidi-Adegani, F., Al-Kindi, J., Vakilian, S., Al-Fahdi, F., Rezaei, R., Al-Adawi, S., Alwahaibi, N., Shalaby, A., Al-Harrasi, A., & Al-Hashmi, S. (2026). Incensole enhances anti-tumor immunity and inhibits melanoma progression by modulating macrophage polarization and suppressing metastasis. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04727-2

Vancouver

Jamshidi-Adegani F, Al-Kindi J, Vakilian S, Al-Fahdi F, Rezaei R, Al-Adawi S, et al. Incensole enhances anti-tumor immunity and inhibits melanoma progression by modulating macrophage polarization and suppressing metastasis. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-025-04727-2

BibTeX
@article{JamshidiAdegani2026,
  author = {Jamshidi-Adegani, Fatemeh and Al-Kindi, Juhaina and Vakilian, Saeid and Al-Fahdi, Fahad and Rezaei, Raziyeh and Al-Adawi, Salim and Alwahaibi, Nasar and Shalaby, Asem and Al-Harrasi, Ahmed and Al-Hashmi, Sulaiman},
  title = {Incensole enhances anti-tumor immunity and inhibits melanoma progression by modulating macrophage polarization and suppressing metastasis},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-025-04727-2}
}
Kostenlos starten →